Khani Soghra, Azizi Marzieh, Elyasi Forouzan, Kamali Mahsa, Moosazadeh Mahmood
Sexual and Reproductive Health Research Centre, School of Nursing and Midwifery, Mazandaran University of Medical Sciences, Sari, Iran.
Department of Psychiatry and Behavioral Sciences Research Center, Mazandaran University of Medical Sciences, Sari, Iran.
Int J Sex Health. 2021 Jul 12;33(3):439-472. doi: 10.1080/19317611.2021.1926039. eCollection 2021.
Despite the noticeable advances in sexual dysfunction (SD) research in the menopausal period, scientific literature showed different reports on the prevalence of SD in the menopausal stages. The primary objective of this study was to systematically review and meta-analysis the prevalence of SD in the different menopausal stages and then meta-analysis the included studies in domains of SD separately. In this systematic review and meta-analysis, keywords were retrieved through MeSH strategy and databases such as PubMed/MEDLINE, PsycINFO, Web of Science (ISI), Scopus, ScienceDirect, SID (Scientific Information Database), Magiran, and Google scholar were searched. Manual review of retrieved citations identified additional citations. The quality of the included studies was assessed using The Newcastle-Ottawa Scale. The main outcome measure in this study was the prevalence of SD in three stages of menopause such as pre, peri, and postmenopause. Of 54 included studies 81,227 menopausal aged women from different menopause stages participated and the sample sizes varied from 49 to 31,581 individuals. The articles from 17 countries worldwide were included in this study. The prevalence of SD in premenopausal aged women was ranged between 22.7% and 72.2%, in perimenopausal aged women, was 37.3-78.2% and also in postmenopausal aged women was extremely reported a wide variety of prevalence ranges and was estimated between 8.7% and 89.01%. The premenopausal women had a lower prevalence of SD compared to other stages of the menopausal period. The results indicated that the prevalence of SD and also domains of SD in different studies were reported much widely. This study can be used as a good resource for obstetricians to understand the high possibility of recurrence of SD and assess the sexual activity of menopausal aged women in the menopause clinic. However, based on the systematic review, more standard and high-quality studies are needed to perform regarding the prevalence of SD in menopausal periods.
尽管更年期性功能障碍(SD)研究取得了显著进展,但科学文献对更年期各阶段SD的患病率报道不一。本研究的主要目的是系统评价和荟萃分析不同更年期阶段SD的患病率,然后分别对SD各领域纳入的研究进行荟萃分析。在这项系统评价和荟萃分析中,通过医学主题词(MeSH)策略检索关键词,并检索了PubMed/MEDLINE、PsycINFO、科学网(ISI)、Scopus、ScienceDirect、SID(科学信息数据库)、Magiran和谷歌学术等数据库。对检索到的文献进行人工筛选以识别其他文献。采用纽卡斯尔-渥太华量表评估纳入研究质量。本研究的主要结局指标是绝经前、围绝经期和绝经后三个更年期阶段SD的患病率。纳入的54项研究中,来自不同更年期阶段的81227名更年期女性参与其中,样本量从49人到31581人不等。本研究纳入了来自全球17个国家的文章。绝经前女性SD的患病率在22.7%至72.2%之间,围绝经期女性为37.3%至78.2%,绝经后女性报道的患病率范围也非常广泛,估计在8.7%至89.01%之间。与更年期其他阶段相比,绝经前女性SD的患病率较低。结果表明,不同研究中SD的患病率及其各领域的报道差异很大。本研究可为产科医生了解SD复发的高可能性以及评估更年期门诊更年期女性的性活动提供良好参考。然而,基于系统评价,仍需要更多规范和高质量的研究来探讨更年期SD的患病率。